open access

Vol 65, No 2 (2007)
Other
Published online: 2007-02-23
Submitted: 2012-12-28
Get Citation

Evidence-based cardiology
Porównanie skuteczności monoterapii rosiglitazonem, metforminą lub gliburidem u chorych na cukrzycę typu 2 świeżo wykrytą
Commentary to the article:
Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43

Cezary Sosnowski, Ewa Janeczko-Sosnowska
Kardiol Pol 2007;65(2):214-216.

open access

Vol 65, No 2 (2007)
Other
Published online: 2007-02-23
Submitted: 2012-12-28

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Evidence-based cardiology
Porównanie skuteczności monoterapii rosiglitazonem, metforminą lub gliburidem u chorych na cukrzycę typu 2 świeżo wykrytą
Commentary to the article:
Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 65, No 2 (2007)

Pages

214-216

Published online

2007-02-23

Bibliographic record

Kardiol Pol 2007;65(2):214-216.

Authors

Cezary Sosnowski
Ewa Janeczko-Sosnowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl